NCT02603861View on ClinicalTrials.gov

A Study of LY3154207 on Sleep in Healthy Male Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Healthy
Interventions
DRUG

LY3154207

LY3154207 administered orally.

DRUG

Placebo

Placebo administered orally.

DRUG

Modafinil

Modafinil administered orally.

Trial Locations (1)

91206

Parexel Early Phase Unit at Glendale, Glendale

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT02603861 - A Study of LY3154207 on Sleep in Healthy Male Participants | Biotech Hunter | Biotech Hunter